-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Isracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative Pharmacy
Isracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative Pharmacy
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, has signed a distribution agreement for Praesidio Health products with Pure Integrative Pharmacy. Pure Integrative Pharmacy includes 17 locations in British Columbia, Canada.
"I am excited to announce our first executed distribution agreement in Canada", stated CEO Phil Floucault. "The Praesidio team has been working hard to bring our NPN formulations forward and get them into the hands of consumers. Pure Integrative Pharmacy, with their commitment to evidence-based complementary medicines and cutting-edge products, is a perfect fit for Praesidio Health products. This is the first step in delivering on our commitment to our shareholders of having products at market in Q4 2022. We are very excited to be working with the team at PURE and view this contract as the catalyst for expanding our distribution network not only in Canada, but throughout North America."
Praesidio is developing natural health products ("NHPs") using an evidence-based process. The company is actively developing several NHP candidates for utility in a range of conditions, including post-viral exposure prophylaxis, urological, anxiety/stress, immune boosting, and sleep aids. Praesidio has submitted all first round product formulations to Health Canada for review and approval as natural health products.
Photo by Richard T on Unsplash
Related News
US Cannabis Council & Other Marijuana Players Just Made Some Key Executive Changes You Should Know About
Cannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private Placement
Isracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health Canada
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, has signed a distribution agreement for Praesidio Health products with Pure Integrative Pharmacy. Pure Integrative Pharmacy includes 17 locations in British Columbia, Canada.
Isracann Biosciences Inc.(OTCPK:ISCNF)(CSE:IPOT)(XFRA:A2PT0E)一个多方面的组织,具有天然保健医学部 (普雷西迪奥健康)和以色列的控股公司签署了一份分销协议对于Praesidio保健品,纯中西医结合的药房。纯正综合药房在加拿大不列颠哥伦比亚省有17个分店。
"I am excited to announce our first executed distribution agreement in Canada", stated CEO Phil Floucault. "The Praesidio team has been working hard to bring our NPN formulations forward and get them into the hands of consumers. Pure Integrative Pharmacy, with their commitment to evidence-based complementary medicines and cutting-edge products, is a perfect fit for Praesidio Health products. This is the first step in delivering on our commitment to our shareholders of having products at market in Q4 2022. We are very excited to be working with the team at PURE and view this contract as the catalyst for expanding our distribution network not only in Canada, but throughout North America."
首席执行官说:我很兴奋地宣布我们在加拿大签署的第一份分销协议。菲尔·弗洛科。Praesidio团队一直在努力将我们的NPN配方推向消费者手中。Pure Integrative Pharmacy致力于以证据为基础的补充药物和尖端产品,非常适合Praesidio保健产品。这是履行我们对股东的承诺的第一步,即2022年第四季度将产品推向市场。我们非常高兴能与PURE团队合作,并将这份合同视为扩大我们不仅在加拿大,而且在整个北美分销网络的催化剂。
Praesidio is developing natural health products ("NHPs") using an evidence-based process. The company is actively developing several NHP candidates for utility in a range of conditions, including post-viral exposure prophylaxis, urological, anxiety/stress, immune boosting, and sleep aids. Praesidio has submitted all first round product formulations to Health Canada for review and approval as natural health products.
Praesidio正在使用循证过程开发天然保健品(NHP)。该公司正在积极开发几种NHP候选药物,用于一系列条件,包括病毒暴露后预防、泌尿外科、焦虑/压力、免疫增强和睡眠辅助。Praesidio已将所有第一轮产品配方提交给加拿大卫生部,供审查和批准为天然保健品。
Photo by Richard T on Unsplash
理查德·T在Unspash上的照片
Related News
相关新闻
US Cannabis Council & Other Marijuana Players Just Made Some Key Executive Changes You Should Know About
美国大麻委员会和其他大麻贩子刚刚做出了一些你应该知道的关键高管变动
Cannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private Placement
大麻公司Isracann Biosciences在首批私募中筹集2.34亿美元
Isracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health Canada
Isracann Biosciences的子公司Praesidio Health向加拿大卫生部提交NPNS
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧